|
OMIM |
Link |
Information gain |
01 |
|
SLOS
|
[NCBI]
|
0.00838633
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
0.00829627
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.00470097
|
|
|
ATHS
|
[NCBI]
|
0.00386068
|
|
|
APOE
|
[NCBI]
|
0.0030093
|
|
|
APOB
|
[NCBI]
|
0.00273903
|
|
|
LPL
|
[NCBI]
|
0.00259685
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.00257657
|
|
|
LCAT
|
[NCBI]
|
0.00253281
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 6
|
[NCBI]
|
0.00183604
|
|
|
cholesterol level quantitative trait locus 2
|
[NCBI]
|
0.00183604
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 5
|
[NCBI]
|
0.00183604
|
|
|
NPC1
|
[NCBI]
|
0.00179754
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.00149782
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.00131563
|
|
|
ACG1A
|
[NCBI]
|
0.00131563
|
|
|
TGD
|
[NCBI]
|
0.00114874
|
|
|
dubowitz syndrome
|
[NCBI]
|
0.001121
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
0.00100565
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000995611
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000995611
|
|
|
fatty metamorphosis of viscera
|
[NCBI]
|
0.000995611
|
|
|
GBD1
|
[NCBI]
|
0.000914721
|
|
|
CDAN3
|
[NCBI]
|
0.000903113
|
|
|
sitosterolemia
|
[NCBI]
|
0.000879459
|
|
|
red cell phospholipid defect with hemolysis
|
[NCBI]
|
0.000829986
|
|
|
ABL
|
[NCBI]
|
0.000816918
|
|
|
STAR
|
[NCBI]
|
0.000784959
|
|
|
LDLR
|
[NCBI]
|
0.000758578
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
0.000722228
|
|
|
FED
|
[NCBI]
|
0.000718008
|
|
|
PLTP
|
[NCBI]
|
0.000709036
|
|
|
desmosterolosis
|
[NCBI]
|
0.00065868
|
|
|
carnitine deficiency, myopathic
|
[NCBI]
|
0.000634859
|
|
|
RA
|
[NCBI]
|
0.00063127
|
|
|
DHS
|
[NCBI]
|
0.000539845
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
0.00052458
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000513665
|
|
|
FCHL
|
[NCBI]
|
0.000472927
|
|
|
CDAN2
|
[NCBI]
|
0.00044655
|
|
|
lathosterolosis
|
[NCBI]
|
0.000438943
|
|
|
hyperalphalipoproteinemia
|
[NCBI]
|
0.000428736
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000427221
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
0.000352283
|
|
|
PFIC1
|
[NCBI]
|
0.000342294
|
|
|
CDPX2
|
[NCBI]
|
0.000295263
|
|
|
ABCA1
|
[NCBI]
|
0.000273227
|
|
|
CF
|
[NCBI]
|
0.000268494
|
|
|
PCOS1
|
[NCBI]
|
0.000245829
|
|
|
SLE
|
[NCBI]
|
0.000240461
|
|
|
DHCR7
|
[NCBI]
|
0.00023526
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
0.000234923
|
|
|
mevalonic aciduria
|
[NCBI]
|
0.000234923
|
|
|
pericardial effusion, chronic
|
[NCBI]
|
0.000219384
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
0.000213834
|
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects
|
[NCBI]
|
0.00020946
|
|
|
CMRD
|
[NCBI]
|
0.00020946
|
|
|
APOA1
|
[NCBI]
|
0.000200857
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
0.000199707
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
0.000199707
|
|
|
NR1H3
|
[NCBI]
|
0.000188328
|
|
|
VEGF
|
[NCBI]
|
0.000188025
|
|
|
NPC1
|
[NCBI]
|
0.000184862
|
|
|
lipase deficiency, combined
|
[NCBI]
|
0.000156572
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
0.000155595
|
|
|
SOAT1
|
[NCBI]
|
0.000155427
|
|
|
STARD3
|
[NCBI]
|
0.000155427
|
|
|
LIPC
|
[NCBI]
|
0.000152995
|
|
|
NR1H4
|
[NCBI]
|
0.00015219
|
|
|
CRC
|
[NCBI]
|
0.000151743
|
|
|
PRL
|
[NCBI]
|
0.000129348
|
|
|
EGF
|
[NCBI]
|
0.000128339
|
|
|
OSBP
|
[NCBI]
|
0.000127396
|
|
|
refsum disease
|
[NCBI]
|
0.000126967
|
|
|
AVP
|
[NCBI]
|
0.000126375
|
|
|
NR0B2
|
[NCBI]
|
0.000123172
|
|
|
ALGS1
|
[NCBI]
|
0.000116507
|
|
|
NGFB
|
[NCBI]
|
0.000115258
|
|
|
PCNA
|
[NCBI]
|
0.000110086
|
|
|
spondylometaphyseal dysplasia, algerian type
|
[NCBI]
|
0.00010967
|
|
|
bile acid, synthetic defect of
|
[NCBI]
|
0.00010967
|
|
|
wolman disease with hypolipoproteinemia and acanthocytosis
|
[NCBI]
|
0.00010967
|
|
|
hypertrophic neuropathy and cataract
|
[NCBI]
|
0.00010967
|
|
|
hyperlipoproteinemia, type iv
|
[NCBI]
|
0.00010967
|
|
|
gallbladder disease 4
|
[NCBI]
|
0.00010967
|
|
|
TH
|
[NCBI]
|
0.000107087
|
|
|
CEACAM5
|
[NCBI]
|
0.000106999
|
|
|
PON1
|
[NCBI]
|
0.000106699
|
|
|
PHA
|
[NCBI]
|
0.0001022
|
|
|
MBTPS1
|
[NCBI]
|
0.000101682
|
|
|
AD
|
[NCBI]
|
0.00010079
|
|
|
VIP
|
[NCBI]
|
9.90399e-05
|
|
|
ABCG5
|
[NCBI]
|
9.86855e-05
|
|
|
ARH
|
[NCBI]
|
9.80283e-05
|
|
|
PPARA
|
[NCBI]
|
9.57856e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
9.53751e-05
|
|
|
SREBF1
|
[NCBI]
|
9.50291e-05
|
|
|
TNF
|
[NCBI]
|
9.42337e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
9.07676e-05
|
|
|
ACHE
|
[NCBI]
|
8.94407e-05
|
|
|
ARMD1
|
[NCBI]
|
8.30447e-05
|
|
|
CRH
|
[NCBI]
|
8.24155e-05
|
|
|
wolman disease
|
[NCBI]
|
7.99578e-05
|
|
|
KLK3
|
[NCBI]
|
7.93526e-05
|
|
|
EPO
|
[NCBI]
|
7.87861e-05
|
|
|
GFAP
|
[NCBI]
|
7.85832e-05
|
|
|
acrogeria, gottron type
|
[NCBI]
|
7.82645e-05
|
|
|
ichthyosis hystrix gravior
|
[NCBI]
|
7.82645e-05
|
|
|
nonarteritic anterior ischemic optic neuropathy, susceptibility to
|
[NCBI]
|
7.82645e-05
|
|
|
RNS
|
[NCBI]
|
7.82645e-05
|
|
|
corpus callosum, partial agenesis of, x-linked
|
[NCBI]
|
7.82645e-05
|
|
|
hemolytic anemia with thermal sensitivity of red cells
|
[NCBI]
|
7.82645e-05
|
|
|
schneckenbecken dysplasia
|
[NCBI]
|
7.82645e-05
|
|
|
SCP2
|
[NCBI]
|
7.75707e-05
|
|
|
NPY
|
[NCBI]
|
7.49632e-05
|
|
|
AFP
|
[NCBI]
|
7.46528e-05
|
|
|
PTH
|
[NCBI]
|
7.35725e-05
|
|
|
NIDDM
|
[NCBI]
|
7.34499e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
7.24063e-05
|
|
|
ABCG8
|
[NCBI]
|
7.23923e-05
|
|
|
srebp cleavage-activating protein
|
[NCBI]
|
6.95e-05
|
|
|
NR1H2
|
[NCBI]
|
6.95e-05
|
|
|
SREBF2
|
[NCBI]
|
6.95e-05
|
|
|
INSIG2
|
[NCBI]
|
6.6968e-05
|
|
|
CYP46A1
|
[NCBI]
|
6.69677e-05
|
|
|
cholesteryl ester transfer protein deficiency
|
[NCBI]
|
6.65264e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
6.65264e-05
|
|
|
ceroid storage disease
|
[NCBI]
|
6.65264e-05
|
|
|
HOA
|
[NCBI]
|
6.65264e-05
|
|
|
CYP27A1
|
[NCBI]
|
6.47162e-05
|
|
|
CYP7A1
|
[NCBI]
|
6.26886e-05
|
|
|
AR
|
[NCBI]
|
6.18883e-05
|
|
|
FPLD2
|
[NCBI]
|
6.15538e-05
|
|
|
NPPA
|
[NCBI]
|
6.13229e-05
|
|
|
SC5DL
|
[NCBI]
|
6.10325e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
5.89688e-05
|
|
|
EGFR
|
[NCBI]
|
5.62775e-05
|
|
|
SHH
|
[NCBI]
|
5.5737e-05
|
|
|
SCARB1
|
[NCBI]
|
5.47963e-05
|
|
|
OKS
|
[NCBI]
|
5.33967e-05
|
|
|
bile acid synthesis defect, congenital, 4
|
[NCBI]
|
5.33967e-05
|
|
|
SHBG
|
[NCBI]
|
5.32039e-05
|
|
|
APOM
|
[NCBI]
|
5.23403e-05
|
|
|
PD
|
[NCBI]
|
5.15933e-05
|
|
|
bile acid synthesis defect, congenital, 1
|
[NCBI]
|
4.89939e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
4.89939e-05
|
|
|
anderson disease
|
[NCBI]
|
4.89939e-05
|
|
|
ABCA2
|
[NCBI]
|
4.85332e-05
|
|
|
ALD
|
[NCBI]
|
4.75733e-05
|
|
|
PRKAA2
|
[NCBI]
|
4.65376e-05
|
|
|
CD
|
[NCBI]
|
4.5839e-05
|
|
|
INSIG1
|
[NCBI]
|
4.47732e-05
|
|
|
HMGCR
|
[NCBI]
|
4.47732e-05
|
|
|
MVK
|
[NCBI]
|
4.25303e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
4.22831e-05
|
|
|
HPP
|
[NCBI]
|
4.22831e-05
|
|
|
NPC2
|
[NCBI]
|
4.17612e-05
|
|
|
BDNF
|
[NCBI]
|
4.11363e-05
|
|
|
LDLRAP1
|
[NCBI]
|
4.0454e-05
|
|
|
CEL
|
[NCBI]
|
3.99951e-05
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
3.96129e-05
|
|
|
APOH
|
[NCBI]
|
3.93153e-05
|
|
|
PCSK9
|
[NCBI]
|
3.92514e-05
|
|
|
TNFSF6
|
[NCBI]
|
3.87315e-05
|
|
|
CJD
|
[NCBI]
|
3.86273e-05
|
|
|
ALB
|
[NCBI]
|
3.82018e-05
|
|
|
CH25H
|
[NCBI]
|
3.7878e-05
|
|
|
ABCB11
|
[NCBI]
|
3.76286e-05
|
|
|
CFTR
|
[NCBI]
|
3.7012e-05
|
|
|
CYP11A1
|
[NCBI]
|
3.61348e-05
|
|
|
APOA4
|
[NCBI]
|
3.61348e-05
|
|
|
PLA2G7
|
[NCBI]
|
3.52264e-05
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
3.51646e-05
|
|
|
TFPI
|
[NCBI]
|
3.48895e-05
|
|
|
MIRN122A
|
[NCBI]
|
3.47448e-05
|
|
|
SQLE
|
[NCBI]
|
3.47448e-05
|
|
|
ADA
|
[NCBI]
|
3.46953e-05
|
|
|
EBP
|
[NCBI]
|
3.4371e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
3.41811e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
3.32759e-05
|
|
|
VED
|
[NCBI]
|
3.32759e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
3.32759e-05
|
|
|
RXRA
|
[NCBI]
|
3.27973e-05
|
|
|
DHCR24
|
[NCBI]
|
3.23528e-05
|
|
|
NPHS1
|
[NCBI]
|
3.15605e-05
|
|
|
PMD
|
[NCBI]
|
3.15158e-05
|
|
|
INS
|
[NCBI]
|
3.06494e-05
|
|
|
NR1I2
|
[NCBI]
|
3.05107e-05
|
|
|
RXRG
|
[NCBI]
|
3.04173e-05
|
|
|
PCTP
|
[NCBI]
|
3.04173e-05
|
|
|
CDS
|
[NCBI]
|
2.99917e-05
|
|
|
pituitary dwarfism due to isolated growth hormone deficiency, autosomal dominant
|
[NCBI]
|
2.99917e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
2.99917e-05
|
|
|
LBR
|
[NCBI]
|
2.88116e-05
|
|
|
TYMS
|
[NCBI]
|
2.86332e-05
|
|
|
APOF
|
[NCBI]
|
2.85484e-05
|
|
|
MADA
|
[NCBI]
|
2.85484e-05
|
|
|
EAOH
|
[NCBI]
|
2.85484e-05
|
|
|
FABP2
|
[NCBI]
|
2.83473e-05
|
|
|
VDR
|
[NCBI]
|
2.81336e-05
|
|
|
ABS
|
[NCBI]
|
2.72138e-05
|
|
|
PHS
|
[NCBI]
|
2.72138e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
2.72138e-05
|
|
|
CYP51A1
|
[NCBI]
|
2.63218e-05
|
|
|
DCE
|
[NCBI]
|
2.63218e-05
|
|
|
STARD6
|
[NCBI]
|
2.63218e-05
|
|
|
CCDC2
|
[NCBI]
|
2.63218e-05
|
|
|
STARD4
|
[NCBI]
|
2.63218e-05
|
|
|
CCI
|
[NCBI]
|
2.63218e-05
|
|
|
STARD5
|
[NCBI]
|
2.63218e-05
|
|
|
APOA5
|
[NCBI]
|
2.61651e-05
|
|
|
RXRB
|
[NCBI]
|
2.61651e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
2.59745e-05
|
|
|
PPARG
|
[NCBI]
|
2.5048e-05
|
|
|
MHA
|
[NCBI]
|
2.37382e-05
|
|
|
CHNG1
|
[NCBI]
|
2.37382e-05
|
|
|
osteoarthritis
|
[NCBI]
|
2.27241e-05
|
|
|
CCKAR
|
[NCBI]
|
2.23728e-05
|
|
|
AHR
|
[NCBI]
|
2.23221e-05
|
|
|
OCRL
|
[NCBI]
|
2.177e-05
|
|
|
LPA
|
[NCBI]
|
2.09617e-05
|
|
|
APC
|
[NCBI]
|
2.05759e-05
|
|
|
GAPDH
|
[NCBI]
|
2.01918e-05
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
2.002e-05
|
|
|
NR5A2
|
[NCBI]
|
1.96529e-05
|
|
|
LRP1
|
[NCBI]
|
1.9619e-05
|
|
|
TG
|
[NCBI]
|
1.92999e-05
|
|
|
POMC
|
[NCBI]
|
1.9153e-05
|
|
|
STARD3NL
|
[NCBI]
|
1.89377e-05
|
|
|
HHAT
|
[NCBI]
|
1.89377e-05
|
|
|
TFCP2L1
|
[NCBI]
|
1.89377e-05
|
|
|
OSBP2
|
[NCBI]
|
1.89377e-05
|
|
|
ERLIN1
|
[NCBI]
|
1.89377e-05
|
|
|
g-substrate
|
[NCBI]
|
1.89377e-05
|
|
|
ADRB3
|
[NCBI]
|
1.85392e-05
|
|
|
SCD
|
[NCBI]
|
1.81108e-05
|
|
|
CCR2
|
[NCBI]
|
1.80287e-05
|
|
|
PPARD
|
[NCBI]
|
1.80287e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
1.77249e-05
|
|
|
CNTF
|
[NCBI]
|
1.77237e-05
|
|
|
krabbe disease
|
[NCBI]
|
1.74809e-05
|
|
|
ABCC2
|
[NCBI]
|
1.73017e-05
|
|
|
CHAC
|
[NCBI]
|
1.7034e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
1.7034e-05
|
|
|
DBI
|
[NCBI]
|
1.69743e-05
|
|
|
COMT
|
[NCBI]
|
1.67352e-05
|
|
|
WBS
|
[NCBI]
|
1.65101e-05
|
|
|
CYP7B1
|
[NCBI]
|
1.61751e-05
|
|
|
CHK
|
[NCBI]
|
1.61751e-05
|
|
|
GRHL1
|
[NCBI]
|
1.61751e-05
|
|
|
ERLIN2
|
[NCBI]
|
1.61751e-05
|
|
|
FOSL2
|
[NCBI]
|
1.61751e-05
|
|
|
ELOVL3
|
[NCBI]
|
1.61751e-05
|
|
|
UBP1
|
[NCBI]
|
1.61751e-05
|
|
|
G6PC3
|
[NCBI]
|
1.61751e-05
|
|
|
SCG3
|
[NCBI]
|
1.61751e-05
|
|
|
SULT2B1
|
[NCBI]
|
1.61751e-05
|
|
|
CRP
|
[NCBI]
|
1.58342e-05
|
|
|
obesity
|
[NCBI]
|
1.51474e-05
|
|
|
PTPN1
|
[NCBI]
|
1.50883e-05
|
|
|
MPO
|
[NCBI]
|
1.49991e-05
|
|
|
NPC1L1
|
[NCBI]
|
1.43949e-05
|
|
|
ABCA7
|
[NCBI]
|
1.43949e-05
|
|
|
IDI1
|
[NCBI]
|
1.43949e-05
|
|
|
FDFT1
|
[NCBI]
|
1.43949e-05
|
|
|
MALL
|
[NCBI]
|
1.43949e-05
|
|
|
APOD
|
[NCBI]
|
1.41803e-05
|
|
|
CES1
|
[NCBI]
|
1.40776e-05
|
|
|
CETP
|
[NCBI]
|
1.37657e-05
|
|
|
MBP
|
[NCBI]
|
1.3242e-05
|
|
|
SLC2A10
|
[NCBI]
|
1.30813e-05
|
|
|
PCQAP
|
[NCBI]
|
1.30813e-05
|
|
|
UCP1
|
[NCBI]
|
1.26052e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.21065e-05
|
|
|
APOC2
|
[NCBI]
|
1.21065e-05
|
|
|
ITIH4
|
[NCBI]
|
1.20424e-05
|
|
|
LMF1
|
[NCBI]
|
1.20424e-05
|
|
|
ABCG1
|
[NCBI]
|
1.20424e-05
|
|
|
NSDHL
|
[NCBI]
|
1.20424e-05
|
|
|
VPS4A
|
[NCBI]
|
1.20424e-05
|
|
|
ANXA4
|
[NCBI]
|
1.20424e-05
|
|
|
LYPLA3
|
[NCBI]
|
1.20424e-05
|
|
|
SOAT2
|
[NCBI]
|
1.20424e-05
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
1.20424e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.17281e-05
|
|
|
LAT
|
[NCBI]
|
1.1412e-05
|
|
|
ACP5
|
[NCBI]
|
1.12666e-05
|
|
|
OSBPL2
|
[NCBI]
|
1.11852e-05
|
|
|
ARMET
|
[NCBI]
|
1.11852e-05
|
|
|
PPARGC1B
|
[NCBI]
|
1.11852e-05
|
|
|
LIPE
|
[NCBI]
|
1.11852e-05
|
|
|
PON3
|
[NCBI]
|
1.11852e-05
|
|
|
ABCD2
|
[NCBI]
|
1.11852e-05
|
|
|
ACAT2
|
[NCBI]
|
1.11852e-05
|
|
|
FABP4
|
[NCBI]
|
1.11852e-05
|
|
|
LSS
|
[NCBI]
|
1.11852e-05
|
|
|
XDH
|
[NCBI]
|
1.09302e-05
|
|
|
LEPR
|
[NCBI]
|
1.08894e-05
|
|
|
CLU
|
[NCBI]
|
1.08894e-05
|
|
|
SLC2A4
|
[NCBI]
|
1.08071e-05
|
|
|
PF4
|
[NCBI]
|
1.07482e-05
|
|
|
PTK2
|
[NCBI]
|
1.05658e-05
|
|
|
PEMT
|
[NCBI]
|
1.05262e-05
|
|
|
MMP3
|
[NCBI]
|
1.05262e-05
|
|
|
LIPG
|
[NCBI]
|
1.0457e-05
|
|
|
LRPAP1
|
[NCBI]
|
1.0457e-05
|
|
|
SPRY1
|
[NCBI]
|
1.0457e-05
|
|
|
HSD17B3
|
[NCBI]
|
1.0457e-05
|
|
|
LAMP1
|
[NCBI]
|
1.0457e-05
|
|
|
CAT
|
[NCBI]
|
1.04544e-05
|
|
|
DJS
|
[NCBI]
|
9.96967e-06
|
|
|
TTR
|
[NCBI]
|
9.8854e-06
|
|
|
CD3D
|
[NCBI]
|
9.82524e-06
|
|
|
ANTXR2
|
[NCBI]
|
9.82524e-06
|
|
|
glycogen storage disease vi
|
[NCBI]
|
9.82524e-06
|
|
|
PDZK1
|
[NCBI]
|
9.82524e-06
|
|
|
RP1
|
[NCBI]
|
9.82524e-06
|
|
|
ICMT
|
[NCBI]
|
9.82524e-06
|
|
|
AMACR
|
[NCBI]
|
9.75167e-06
|
|
|
VLDLR
|
[NCBI]
|
9.75167e-06
|
|
|
SVAS
|
[NCBI]
|
9.5997e-06
|
|
|
CTGF
|
[NCBI]
|
9.49384e-06
|
|
|
EPHX2
|
[NCBI]
|
9.26842e-06
|
|
|
ACACB
|
[NCBI]
|
9.26842e-06
|
|
|
AGT
|
[NCBI]
|
9.22046e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
9.1636e-06
|
|
|
sandhoff disease
|
[NCBI]
|
8.89886e-06
|
|
|
ATP8B1
|
[NCBI]
|
8.77143e-06
|
|
|
POR
|
[NCBI]
|
8.77143e-06
|
|
|
MDD
|
[NCBI]
|
8.75144e-06
|
|
|
APP
|
[NCBI]
|
8.58677e-06
|
|
|
MSR1
|
[NCBI]
|
8.32334e-06
|
|
|
FRAP1
|
[NCBI]
|
8.04742e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
8.03004e-06
|
|
|
ADCYAP1
|
[NCBI]
|
7.94657e-06
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
7.93673e-06
|
|
|
FGF7
|
[NCBI]
|
7.92255e-06
|
|
|
ZNF9
|
[NCBI]
|
7.91598e-06
|
|
|
SLC17A5
|
[NCBI]
|
7.91598e-06
|
|
|
CYP3A5
|
[NCBI]
|
7.54306e-06
|
|
|
ANXA2
|
[NCBI]
|
7.54306e-06
|
|
|
ATP5O
|
[NCBI]
|
7.19964e-06
|
|
|
APOC3
|
[NCBI]
|
7.19964e-06
|
|
|
ATXN2
|
[NCBI]
|
7.19964e-06
|
|
|
ABCD1
|
[NCBI]
|
6.92803e-06
|
|
|
THBD
|
[NCBI]
|
6.88178e-06
|
|
|
PGR
|
[NCBI]
|
6.74525e-06
|
|
|
G6PD
|
[NCBI]
|
6.61156e-06
|
|
|
MTP
|
[NCBI]
|
6.58628e-06
|
|
|
MAPK9
|
[NCBI]
|
6.58628e-06
|
|
|
ATRN
|
[NCBI]
|
6.58628e-06
|
|
|
ABCB4
|
[NCBI]
|
6.58628e-06
|
|
|
GCCR
|
[NCBI]
|
6.57704e-06
|
|
|
CDSP
|
[NCBI]
|
6.53889e-06
|
|
|
HD
|
[NCBI]
|
6.49192e-06
|
|
|
ADAM10
|
[NCBI]
|
6.31051e-06
|
|
|
CDH2
|
[NCBI]
|
6.31051e-06
|
|
|
CLDN11
|
[NCBI]
|
6.31051e-06
|
|
|
CCK
|
[NCBI]
|
6.29016e-06
|
|
|
F3
|
[NCBI]
|
6.14342e-06
|
|
|
CHS
|
[NCBI]
|
6.1187e-06
|
|
|
ANGPT2
|
[NCBI]
|
6.05226e-06
|
|
|
NCOA1
|
[NCBI]
|
6.05226e-06
|
|
|
CD40
|
[NCBI]
|
6.05226e-06
|
|
|
hypertension, essential
|
[NCBI]
|
6.04249e-06
|
|
|
CP
|
[NCBI]
|
6.00499e-06
|
|
|
PHB
|
[NCBI]
|
5.8097e-06
|
|
|
TXNIP
|
[NCBI]
|
5.8097e-06
|
|
|
ABP1
|
[NCBI]
|
5.75376e-06
|
|
|
IDDM
|
[NCBI]
|
5.6402e-06
|
|
|
CAPN10
|
[NCBI]
|
5.58124e-06
|
|
|
CSF1
|
[NCBI]
|
5.36555e-06
|
|
|
LRP2
|
[NCBI]
|
5.36555e-06
|
|
|
SMS
|
[NCBI]
|
5.35696e-06
|
|
|
ACACA
|
[NCBI]
|
5.16146e-06
|
|
|
SPP1
|
[NCBI]
|
5.0957e-06
|
|
|
ACPP
|
[NCBI]
|
5.06973e-06
|
|
|
SOD2
|
[NCBI]
|
5.05915e-06
|
|
|
EGR2
|
[NCBI]
|
4.96797e-06
|
|
|
GHSR
|
[NCBI]
|
4.96797e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
4.93611e-06
|
|
|
PSORS1
|
[NCBI]
|
4.93611e-06
|
|
|
HP
|
[NCBI]
|
4.92069e-06
|
|
|
LRP5
|
[NCBI]
|
4.78419e-06
|
|
|
ANXA5
|
[NCBI]
|
4.60934e-06
|
|
|
PIAS1
|
[NCBI]
|
4.60934e-06
|
|
|
AT
|
[NCBI]
|
4.53217e-06
|
|
|
MTND2
|
[NCBI]
|
4.44273e-06
|
|
|
THRA
|
[NCBI]
|
4.44273e-06
|
|
|
TP73L
|
[NCBI]
|
4.44273e-06
|
|
|
CYP1A1
|
[NCBI]
|
4.35714e-06
|
|
|
MYD88
|
[NCBI]
|
4.28376e-06
|
|
|
CYP11B1
|
[NCBI]
|
4.28376e-06
|
|
|
STAT3
|
[NCBI]
|
4.08261e-06
|
|
|
CAV1
|
[NCBI]
|
3.84746e-06
|
|
|
FPRL1
|
[NCBI]
|
3.84746e-06
|
|
|
SMPD1
|
[NCBI]
|
3.84746e-06
|
|
|
MET
|
[NCBI]
|
3.7141e-06
|
|
|
PWS
|
[NCBI]
|
3.6662e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
3.66214e-06
|
|
|
CD2AP
|
[NCBI]
|
3.58613e-06
|
|
|
GPI
|
[NCBI]
|
3.55973e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
3.34866e-06
|
|
|
CYP11B2
|
[NCBI]
|
3.34513e-06
|
|
|
ACE
|
[NCBI]
|
3.31291e-06
|
|
|
CPB2
|
[NCBI]
|
3.25433e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
3.01681e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
2.89091e-06
|
|
|
JAG1
|
[NCBI]
|
2.81737e-06
|
|
|
ADRB2
|
[NCBI]
|
2.81737e-06
|
|
|
ADM
|
[NCBI]
|
2.79947e-06
|
|
|
ESR1
|
[NCBI]
|
2.77393e-06
|
|
|
PI
|
[NCBI]
|
2.63975e-06
|
|
|
ASPA
|
[NCBI]
|
2.63167e-06
|
|
|
UCP2
|
[NCBI]
|
2.58034e-06
|
|
|
AKR1B1
|
[NCBI]
|
2.57209e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
2.54357e-06
|
|
|
PEPD
|
[NCBI]
|
2.37612e-06
|
|
|
CREBBP
|
[NCBI]
|
2.21951e-06
|
|
|
CYP17A1
|
[NCBI]
|
2.07281e-06
|
|
|
APRT
|
[NCBI]
|
1.96531e-06
|
|
|
RP
|
[NCBI]
|
1.9314e-06
|
|
|
GHR
|
[NCBI]
|
1.92381e-06
|
|
|
PDCD8
|
[NCBI]
|
1.78065e-06
|
|
|
RIPK1
|
[NCBI]
|
1.74441e-06
|
|
|
PVR
|
[NCBI]
|
1.57047e-06
|
|
|
TLR2
|
[NCBI]
|
1.5626e-06
|
|
|
PSAP
|
[NCBI]
|
1.51593e-06
|
|
|
TF
|
[NCBI]
|
1.5035e-06
|
|
|
TLR4
|
[NCBI]
|
1.4982e-06
|
|
|
KLF4
|
[NCBI]
|
1.46301e-06
|
|
|
BCL2
|
[NCBI]
|
1.36181e-06
|
|
|
ATF3
|
[NCBI]
|
1.31343e-06
|
|
|
APCS
|
[NCBI]
|
1.26646e-06
|
|
|
MMP9
|
[NCBI]
|
1.26646e-06
|
|
|
SPTA1
|
[NCBI]
|
1.22087e-06
|
|
|
IRS1
|
[NCBI]
|
1.1766e-06
|
|
|
FRDA
|
[NCBI]
|
1.08186e-06
|
|
|
CYP19A1
|
[NCBI]
|
1.01204e-06
|
|
|
ILK
|
[NCBI]
|
8.84467e-07
|
|
|
MAPK3
|
[NCBI]
|
8.65768e-07
|
|
|
GRP
|
[NCBI]
|
8.05254e-07
|
|
|
LCN2
|
[NCBI]
|
7.98866e-07
|
|
|
MC4R
|
[NCBI]
|
7.98866e-07
|
|
|
JAK2
|
[NCBI]
|
7.89727e-07
|
|
|
ACADM
|
[NCBI]
|
7.55989e-07
|
|
|
THRB
|
[NCBI]
|
7.35826e-07
|
|
|
BMP2
|
[NCBI]
|
6.76448e-07
|
|
|
MODY
|
[NCBI]
|
6.45223e-07
|
|
|
CCL2
|
[NCBI]
|
6.20547e-07
|
|
|
IHH
|
[NCBI]
|
6.10535e-07
|
|
|
GJA1
|
[NCBI]
|
5.16991e-07
|
|
|
SPINK1
|
[NCBI]
|
5.16277e-07
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
4.51683e-07
|
|
|
PMP22
|
[NCBI]
|
4.02424e-07
|
|
|
STC1
|
[NCBI]
|
3.87644e-07
|
|
|
BSG
|
[NCBI]
|
3.87644e-07
|
|
|
HNF1A
|
[NCBI]
|
2.80374e-07
|
|
|
ABCC1
|
[NCBI]
|
2.54006e-07
|
|
|
AGER
|
[NCBI]
|
1.91788e-07
|
|
|
FAAH
|
[NCBI]
|
1.55496e-07
|
|
|
hemophilia a
|
[NCBI]
|
1.49438e-07
|
|
|
PTGS2
|
[NCBI]
|
1.35883e-07
|
|
|
GH1
|
[NCBI]
|
1.16003e-07
|
|
|
NSF
|
[NCBI]
|
1.16003e-07
|
|
|
SMAX1
|
[NCBI]
|
1.15989e-07
|
|
|
BCHE
|
[NCBI]
|
1.11062e-07
|
|
|
SST
|
[NCBI]
|
1.07528e-07
|
|
|
ATM
|
[NCBI]
|
8.95152e-08
|
|
|
LBP
|
[NCBI]
|
8.95152e-08
|
|
|
LEP
|
[NCBI]
|
8.50159e-08
|
|
|
MAP2
|
[NCBI]
|
7.03126e-08
|
|
|
IGFALS
|
[NCBI]
|
6.7153e-08
|
|
|
SDC2
|
[NCBI]
|
5.82533e-08
|
|
|
IDE
|
[NCBI]
|
4.21933e-08
|
|
|
SLC6A4
|
[NCBI]
|
3.98931e-08
|
|
|
KDR
|
[NCBI]
|
3.72623e-08
|
|
|
CCND1
|
[NCBI]
|
3.21479e-08
|
|
|
LPO
|
[NCBI]
|
2.91108e-08
|
|
|
PRKCM
|
[NCBI]
|
2.76727e-08
|
|
|
PLG
|
[NCBI]
|
1.62512e-08
|
|
|
CFH
|
[NCBI]
|
1.32849e-08
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.05385e-08
|
|
|
INSR
|
[NCBI]
|
1.01159e-09
|
|
|
GIP
|
[NCBI]
|
1.43024e-11
|
|